Amarin | Kostnadene For Salg



Cost Of Sales Endring Dato
AbbVie USD 4B 394M 2025-03
Alnylam Pharmaceuticals USD 102.82M 16.91M 2024-12
Amarin USD 26.02M 1.3M 2024-09
AstraZeneca USD 2.24B 484M 2025-03
GlaxoSmithKline GBP 1.92B 635M 2025-03
Halozyme Therapeutics USD 42.06M 7.37M 2024-12
Ionis Pharmaceuticals USD 1000K 2.83M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.32B 90M 2024-12



Amarin Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.